CHAD S LOTT
Allopathic & Osteopathic Physicians|Emergency Medicine MONTGOMERY, AL NPI 1679201305
Browse related groups: Allopathic & Osteopathic Physicians|Emergency Medicine AL Neurocrine BioSciences, Inc. All categories
General Payments — all program years on this page
$241.07
- Category: General Payments
- Program years: PY2022–2024
- Record count: 13
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $141.86 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $141.86 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Neurocrine BioSciences, Inc. | $52.94 | 3 |
| PFIZER INC. | $25.14 | 1 |
| Xeris Pharmaceuticals, Inc. | $24.57 | 1 |
| Lexicon Pharmaceuticals, Inc. | $22.21 | 1 |
| Novo Nordisk AS | $17.00 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1081699205 | Lexicon Pharmaceuticals, Inc. | $22.21 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1108582129 | Novo Nordisk Inc | $17.00 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131395853 | PFIZER INC. | $25.14 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144589888 | Xeris Pharmaceuticals, Inc. | $24.57 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150849564 | Neurocrine Biosciences, Inc. | $22.42 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150873932 | Neurocrine Biosciences, Inc. | $15.34 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150874658 | Neurocrine Biosciences, Inc. | $15.18 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.